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PHARMACY 428 (CHEMOTHERAPEUTIC AGENTS) AUTUMN SEMESTER, 2000
INSTRUCTOR: David Freeman, Office - SB 308 Office Phone: 243-4772 Home Phone: 728-6551 
E-mail: dfreeman@selwav.umt.edu Internet Site: www.umt.edu/pharmacv
EXAMS AND GRADING:
First Exam: Monday, Oct. 9 . 50 points 
Second Exam: Monday, Oct. 30 . 70 points 
Third Exam: Monday, Nov. 27 . 80 points 
Final Exam: .100 points 
10 Point Quizzes: Best 5 out of 6 scores . 50 points
Total Points: 350 90-100% = A 80-89 % = B 70-79 % = C 65-69 % = D
* All EXAMS are comprehensive
* All exams and quizzes must be taken at scheduled times
* Instructor must be informed BEFORE missing a scheduled exam period 
and MUST be based on GOOD REASONS
* Missed exam periods must be made up within 2 days
* No make up quizzes
STUDENT PERFORMANCE OBJECTIVES:
1) Know the normal relevant biochemical pathways and the major biochemical mechanisms
of action for the different classes of drugs
2) Know the biochemical mechanisms involved in the development of resistance to different
classes of antimicrobial agents
3) Given a representative chemical structure or name of a drug, know its biochemical mechanisms
of action and for development of Resistance
4) Given a representative chemical structure or name of a drug, know its major chemical,
pharmacologic, or therapeutic categorization
5) Given a representative chemical structure or name of a drug, know its major
therapeutic uses and spectrum of activity
6) Given a representative chemical structure or name of a drug, know important aspects of its
absorption, pharmacokinetics, and metabolism
7) Know important chemical features (i.e., polar or lipophilic properties, labile groups, etc.) that
affect the absorption, distribution, metabolism, elimination, potency, stability, or formulation 
of a class of antimicrobial agents
8) Given the chemical structure of an antimicrobial agent, know important chemical changes
that will predictably alter its properties (i.e., potency, duration of action, stability, etc.)
9) Given a representative chemical structure or name of a drug, know its most common or serious
adverse or side effects
TEXTBOOK: Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition
Reading 
In Text
1029-1032 
1044 
I. General Considerations, Categorization, and 
Sensitivity Testing of Antimicrobial Agents
The following areas will be covered for each outline topic below:
-General Chemical Structures and Properties of Agents 
-Biochemical Mechanisms of Action for Agents
-Biochemical Mechanisms Involved in the Development of Microbial Resistance 
-Important Aspects of Absorption, Distribution, Metabolism, and Elimination for Agents 
-Antimicrobial Spectrum of Activity for Agents 
-Important Adverse Effects and Drug Interactions for Agents
Reading
In Text
II. Antibacterial Agents
1057-1065 A. Sulfonamides and TRIMETHOPRIM
1065-1068 B. Quinolones, Fluoroquinolones *
C. Beta-lactam Antibiotics
1073-1089 1. Penicillins
1097-1098 2. Beta-lactamase inhibitors (CLAVULANIC ACID, SULBACTAM, TAZOBACTAM)
1089-1096 3. Cephalosporins
1096-1097 4. Carbapenems (IMIPENEM), Carbacephems (LORACARBEF),
Monobactams (AZTREONAM)
1143-1147 D. POLYMYXIN, VANCOMYCIN, TEICHOPLANIN, BACITRACIN
1103-1117 E. Aminoglycosides
1124-1130 F. Tetracyclines
1135-1140 G. Macrolides (ERYTHROMYCIN, AZITHROMYCIN, CLARITHROMYCIN)
1130-1135 H. CHLORAMPHENICOL
1141-1143 I. CLINDAMYCIN
995-998 J. METRONIDAZOLE
1148 K. Streptogramins (QUINUPRISTIN, DALFOPRISTIN)
L. Oxazolidinones (LINEZOLID)
III. Antitubercular Agents
1155-1163 * ISONIAZID RIFAMPIN PYRAZINAMIDE ETHAMBUTOL *
v
IV. Antifungal Agents
1175-1186 * AMPHOTERICIN B MICONAZOLE CLOTRIMAZOLE KETOCONAZOLE *
* FLUCONAZOLE ITRAZONAZOLE GRISEOFULVIN FLUCYTOSINE TERBINAFINE
V. Antiviral Agents
1194 A. Review of Viral DNA and RNA Biochemical Processes
1195 B. Chemistry, Biochemical Mechanisms of Action and Resistance Development
C. Major Pharmacokinetic Properties and Adverse Effects
1191-1203 D. Non-HIV Antiviral Agents
* ACYCLOVIR CIDOFOVIR FAMCICLOVIR FOSCARNET GANCICLOVIR *
* PENCICLOVIR RIBAVIRIN TRIFLURIDINE VALACYCLOVIR CIDOFOVIR *
1209-1214 * ZANAMIVIR OSELTAMIVIR AMANTADINE RIMANTIDINE *
1204-1209 VI. HIV Antiviral Agents
A. Nucleoside Reverse Transcriptase Inhibitors
* ZIDOVUDINE DIDANOSINE STAVUDINE ZALCITABINE *
* LAMIVUDINE ABACAVIR *
1215-1216 B. Non-Nucleoside Reverse Transcriptase Inhibitors
* NEVIRAPINE DELAVIRDINE EFAVIRENZ *
1216-1217 C. Protease Inhibitors
* SAQUINAVIR INDINAVIR RITONAVIR NELFINAVIR AMPRENAVIR *
D. Drugs for Opportunistic Infections
999-1001 * PENTAMIDINE ATOVAQUONE *
